Tech Company Financing Transactions

Embera NeuroTherapeutics Funding Round

Embera NeuroTherapeutics closed a $68 thousand funding round on 12/31/2012. Investors included BVM Capital.

Transaction Overview

Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$68,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
365 Boston Post Rd. 210
Sudbury, MA 01776
USA
Email Address
Not Recorded
Overview
Embera is developing a patent-pending drug combination, EMB-001, that addresses significant unmet needs in smoking cessation and cocaine dependence.
Profile
Embera NeuroTherapeutics LinkedIn Company Profile
Social Media
Embera NeuroTherapeutics Company Twitter Account
Company News
Embera NeuroTherapeutics News
Facebook
Embera NeuroTherapeutics on Facebook
YouTube
Embera NeuroTherapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Linke
  Robert Linke LinkedIn Profile  Robert Linke Twitter Account  Robert Linke News  Robert Linke on Facebook
Vice President
Julie Straub
  Julie Straub LinkedIn Profile  Julie Straub Twitter Account  Julie Straub News  Julie Straub on Facebook
VP - Operations
Gary Connor
  Gary Connor LinkedIn Profile  Gary Connor Twitter Account  Gary Connor News  Gary Connor on Facebook
VP - Regulatory Affairs
Ann Robbins
  Ann Robbins LinkedIn Profile  Ann Robbins Twitter Account  Ann Robbins News  Ann Robbins on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2012: Shasta Crystals venture capital transaction
Next: 12/31/2012: WebLink International venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document all VC transactions involving tech companies. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary